| Literature DB >> 21822411 |
Charline Abed1,2, Nathalie Legrave1, Maeva Dufies3, Guillaume Robert3, Vincent Guérineau4, Jean Vacelet2, Patrick Auberger3, Philippe Amade1, Mohamed Mehiri1.
Abstract
Chemical investigation of the Mediterranean sponge Sarcotragus spinosulus led to the isolation of a new hydroxylated nonaprenylhydroquinone, along with two known metabolites, hepta- and octaprenylhydroquinones. The structure of the new metabolite was assigned by extensive 1D and 2D NMR analyses and MS studies. The antileukemic effect of the three compounds towards the chronic myelogenous leukemia (CML) cells line K562 was also evaluated.Entities:
Keywords: Sarcotragus spinosulus; bioactivity; hydroxylated polyprenylhydroquinone; marine natural products; sponges
Mesh:
Substances:
Year: 2011 PMID: 21822411 PMCID: PMC3148498 DOI: 10.3390/md9071210
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Structure of compounds 1, 2, and 3.
1H NMR (500 MHz, CD3OD) and 13C NMR (125 MHz, CD3OD) data of compound 3.
| No. | δC (ppm) | Mult. | δH (ppm) | Mult. | COSY | HMBC | |
|---|---|---|---|---|---|---|---|
| 1′ | 148.9 | qC | |||||
| 2′ | 130.2 | qC | |||||
| 3′ | 117.2 | CH | 6.52 | 3.00 | d | 1 | 1, 1′, 4′, 5′ |
| 4′ | 151.1 | qC | |||||
| 5′ | 113.8 | CH | 6.41 | 8.50, 3.00 | dd | 6′ | 3′, 4′ |
| 6′ | 116.5 | CH | 6.56 | 8.50 | d | 5′ | 1, 1′, 2, 5′ |
| 1 | 29.1 | CH2 | 3.22 | 7.33 | d | 2 | 1′, 2′, 3, 3′ |
| 2 | 124.0 | CH | 5.30 | m | 1 | 1, 4 | |
| 3 | 136.8 | qC | |||||
| 4 | 40.9 | CH2 | 1.98 | m | 5 | ||
| 5 | 27.7 | CH2 | 2.16 | m | 4, 6 | 3, 4, 6, 7 | |
| 6 | 128.8 | CH | 5.25 | m | 5 | ||
| 7 | 139.4 | qC | |||||
| 8 | 35.9 | CH2 | 2.11 | m | 9 | 9, 6, 10, 38 | |
| 9 | 27.7 | CH2 | 2.05 | m | 8, 10 | ||
| 10 | 125.6 | CH | 5.10 | m | 9 | ||
| 11 | 135.8 | qC | |||||
| 12 | 40.9 | CH2 | 1.96 | m | |||
| 13 | 27.7 | CH2 | 2.05 | m | |||
| 14 | 125.6 | CH | 5.10 | m | |||
| 15 | 135.8 | qC | |||||
| 16 | 40.9 | CH2 | 1.96 | m | |||
| 17 | 27.7 | CH2 | 2.05 | m | |||
| 18 | 125.6 | CH | 5.10 | m | |||
| 19 | 135.8 | qC | |||||
| 20 | 40.9 | CH2 | 1.96 | m | |||
| 21 | 27.7 | CH2 | 2.05 | m | |||
| 22 | 125.6 | CH | 5.10 | m | |||
| 23 | 135.8 | qC | |||||
| 24 | 40.9 | CH2 | 1.96 | m | |||
| 25 | 27.7 | CH2 | 2.05 | m | |||
| 26 | 125.6 | CH | 5.10 | m | |||
| 27 | 135.8 | qC | |||||
| 28 | 40.9 | CH2 | 1.96 | m | |||
| 29 | 27.7 | CH2 | 2.05 | m | |||
| 30 | 125.6 | CH | 5.10 | m | |||
| 31 | 135.8 | qC | |||||
| 32 | 40.9 | CH2 | 1.96 | m | |||
| 33 | 27.7 | CH2 | 2.05 | m | |||
| 34 | 125.6 | CH | 5.10 | m | |||
| 35 | 135.8 | qC | |||||
| 36 | 25.9 | CH3 | 1.65 | s | 34,45 | ||
| 37 | 16.2 | CH3 | 1.69 | s | 1,2 | 2,3,4 | |
| 38 | 60.0 | CH2 | 4.06 | s | 6,7,8 | ||
| 39 | 16.2 | CH3 | 1.58 | s | |||
| 40 | 16.2 | CH3 | 1.58 | s | |||
| 41 | 16.2 | CH3 | 1.58 | s | |||
| 42 | 16.2 | CH3 | 1.58 | s | |||
| 43 | 16.2 | CH3 | 1.58 | s | |||
| 44 | 16.2 | CH3 | 1.58 | s | |||
| 45 | 17.8 | CH3 | 1.58 | s |
IC50 values for Imatinib and compounds 1–3 for loss of cell metabolism (XTT assay) and cell number. Cells (15 × 104/mL) were incubated for 48 h at 37 °C with either increasing concentration of compounds 1–3 in the 2.5–250 μM range or with Imatinib in the 0.1–2.5 μM range. Cell metabolism was measured using the XTT assay and cell numbers was assessed by flow cytometry as indicated in the Experimental section. IC50 values are representative of three experiments made in quadruplicate.
| Compounds | Cell metabolism (IC50) | Cell number (IC50) |
|---|---|---|
| 8 | 7 | |
| 10 | 12 | |
| 193 | 191 | |
| Imatinib | 0.4 | 0.5 |
Figure 2Sarcotragus spinosulus.